Skip to main content

Table 2 Myeloid-specific ikkβ gene deletion regulates the percentages of CD4+, CD4+/IFN-γ+, CD4+/IL-17+, and CD4+/CD25+/Foxp3+ T cells

From: IKKβ-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1/Th17 cell activation and compromising blood brain barrier

A

Spinal cord

PBS

MOG

Wild type

LysM-Cre/IkkβF/F

Wild type

LysM-Cre/IkkβF/F

CD4+

0.52 ± 0.17

0.65 ± 0.21

14.47 ± 1.21##

8.18 ± 0.53**

CD8+

2.53 ± 1.38

2.89 ± 0.13

3.07 ± 0.74

2.76 ± 0.06

CD4+/IFN-γ+

2.97 ± 0.04

2.98 ± 0.95

11.33 ± 0.69##

6.34 ± 0.22**

CD4+/IL-17+

3.84 ± 0.94

3.01 ± 0.12

14.35 ± 1.21##

5.43 ± 0.63**

CD4+/IL-4+

0.41 ± 0.09

0.49 ± 0.29

0.87 ± 0.13

0.94 ± 0.27

CD4+/Foxp3+

0.31 ± 0.45

0.37 ± 0.57

4.59 ± 1.97#

13.49 ± 3.21*

CD4+/CD25+/Foxp3+

0.46 ± 0.06

0.74 ± 0.10

1.55 ± 0.15##

4.05 ± 0.80*

B

    

Lymph node

PBS

MOG

Wild type

LysM-Cre/Ikkβ F/F

Wild type

LysM-Cre/Ikkβ F/F

CD4+

8.43 ± 0.64

8.13 ± 0.84

27.77 ± 2.33##

19.96 ± 2.96*

CD8+

4.85 ± 0.00

4.39 ± 0.10

4.71 ± 1.08

4.06 ± 0.72

CD4+/IFN-γ+

1.01 ± 0.09

1.24 ± 0.01

9.40 ± 1.98##

4.59 ± 0.72*

CD4+/IL-17+

0.13 ± 0.53

0.10 ± 0.34

14.76 ± 2.64##

4.13 ± 0.66**

CD4+/IL-4+

4.55 ± 0.60

4.29 ± 0.52

3.49 ± 1.32##

4.01 ± 0.94

CD4+/Foxp3+

16.49 ± 1.02

15.21 ± 0.37

8.01 ± 1.31#

11.31 ± 0.20*

CD4+/CD25+/Foxp3+

5.00 ± 0.21

4.96 ± 0.57

2.75 ± 0.01##

4.41 ± 0.13**

  1. Spinal cords (A) and lymph nodes (B) were dissected from each group (n = 5) at day 15–18 post-immunization to investigate the degree of differentiation and recruitment/infiltration of CD4+ T cells with flow cytometry. Spot plot graphs and their legends in details can be found in the Additional file 4. Data are represented as mean ± SEM. (ANOVA test; * p < 0.05 and **p < 0.01 versus WT EAE mice; #p < 0.05 and ##p <0.01 versus normal control mice)